In this work,BiOCl/OVs-BiPO_(4)heterojunction photocatalysts were successfully in-situ prepared by treating of BiPO_(4)with dilute hydrochloric acid(HCl)under hydrothermal condition.Systematically characterization res...In this work,BiOCl/OVs-BiPO_(4)heterojunction photocatalysts were successfully in-situ prepared by treating of BiPO_(4)with dilute hydrochloric acid(HCl)under hydrothermal condition.Systematically characterization results confirm that BiOCl/BiPO_(4)heterojunctions have been successfully in-situ constructed and oxygen vacancies(OVs)are significantly increased.The OVs on the surface of the BiOCl/OVS-BiPO_(4)heterojunctions photocatalyst and the interface electric field at the interface of the heterojunctions effectively accelerate the separation and migration of photogenerated carriers,and the surface OVs provide more sites for adsorption and reaction.Consequently,BiOCl/OVs-BiPO_(4)heterojunction photocatalysts have higher separation rate of photoexcited e-/h+pairs and exhibit ascendant photocatalytic degradation activity.Electron paramagnetic resonance(EPR)technology and free radical capture experiments give strong evidence that·O2-exists in the reaction system and is the leading species during the degradation process.The experimental results reveal that the degradation efficiency of rhodamine B(RhB)over BiPO_(4)treated with 3 ml of 0.1%dilute hydrochloric acid(3HCl-BPO)is 2.42 times of that over the reference BiPO_(4).After ultraviolet(UV)light illumination for 20 min,the destruction degree of RhB on the 3HCl-BPO sample reaches 99%.Moreover,the degradation rate of tetracycline(TC)is also obviously improved over 3HCl-BPO compared with that on the reference BiPO_(4)after 40 min exposure to ultraviolet light.The excellent stability of the sample was demonstrated by five cycles.A reasonable enhancement mechanism for BiOCl/OVs-BiPO_(4)heterojunctions was proposed to elucidate the boosted photocatalytic performance.This work offers a facile and reliable reference to design high performance BiPO_(4)-based photocatalysts for environment purification.展开更多
Current treatments for advanced hepatocellular carcinoma(HCC)have limited success in improving patients’quality of life and prolonging life expectancy.The clinical need for more efficient and safe therapies has contr...Current treatments for advanced hepatocellular carcinoma(HCC)have limited success in improving patients’quality of life and prolonging life expectancy.The clinical need for more efficient and safe therapies has contributed to the exploration of emerging strategies.Recently,there has been increased interest in oncolytic viruses(OVs)as a therapeutic modality for HCC.OVs undergo selective replication in cancerous tissues and kill tumor cells.Strikingly,pexastimogene devacirepvec(Pexa-Vec)was granted an orphan drug status in HCC by the U.S.Food and Drug Administration(FDA)in 2013.Meanwhile,dozens of OVs are being tested in HCC-directed clinical and preclinical trials.In this review,the pathogenesis and current therapies of HCC are outlined.Next,we summarize multiple OVs as single therapeutic agents for the treatment of HCC,which have demonstrated certain efficacy and lowtoxicity.Emerging carrier cell-,bioengineered cell mimetic-or nonbiological vehicle-mediated OV intravenous delivery systems in HCC therapy are described.In addition,we highlight the combination treatments between oncolytic virotherapy and other modalities.Finally,the clinical challenges and prospects of OV-based biotherapy are discussed,with the aim of continuing to develop a fascinating approach in HCC patients.展开更多
针对软件定义网络中控制器单点(Software Defined Network,SDN)运行隐患的问题,本文设计一种基于Ryu控制器的一主多备集群式控制器(Cluster Ryu Controller,CRC),实现自定义OVS交换机(OpenVSwitch)连接、事件上报、状态查看、流表下发...针对软件定义网络中控制器单点(Software Defined Network,SDN)运行隐患的问题,本文设计一种基于Ryu控制器的一主多备集群式控制器(Cluster Ryu Controller,CRC),实现自定义OVS交换机(OpenVSwitch)连接、事件上报、状态查看、流表下发等功能。通过Ryu+mininet工具进行仿真实验,结果表明,当CRC中某一控制器出现故障时,不会影响到CRC与整个网络的稳定运行,有效提升SDN网络的健壮性与可靠性。展开更多
基金supported by Sichuan University of Science and Engineering(No.2021RC26)Chemical Synthesis and Pollution Control Key Laboratory of Sichuan Province(No.CSPC202105).
文摘In this work,BiOCl/OVs-BiPO_(4)heterojunction photocatalysts were successfully in-situ prepared by treating of BiPO_(4)with dilute hydrochloric acid(HCl)under hydrothermal condition.Systematically characterization results confirm that BiOCl/BiPO_(4)heterojunctions have been successfully in-situ constructed and oxygen vacancies(OVs)are significantly increased.The OVs on the surface of the BiOCl/OVS-BiPO_(4)heterojunctions photocatalyst and the interface electric field at the interface of the heterojunctions effectively accelerate the separation and migration of photogenerated carriers,and the surface OVs provide more sites for adsorption and reaction.Consequently,BiOCl/OVs-BiPO_(4)heterojunction photocatalysts have higher separation rate of photoexcited e-/h+pairs and exhibit ascendant photocatalytic degradation activity.Electron paramagnetic resonance(EPR)technology and free radical capture experiments give strong evidence that·O2-exists in the reaction system and is the leading species during the degradation process.The experimental results reveal that the degradation efficiency of rhodamine B(RhB)over BiPO_(4)treated with 3 ml of 0.1%dilute hydrochloric acid(3HCl-BPO)is 2.42 times of that over the reference BiPO_(4).After ultraviolet(UV)light illumination for 20 min,the destruction degree of RhB on the 3HCl-BPO sample reaches 99%.Moreover,the degradation rate of tetracycline(TC)is also obviously improved over 3HCl-BPO compared with that on the reference BiPO_(4)after 40 min exposure to ultraviolet light.The excellent stability of the sample was demonstrated by five cycles.A reasonable enhancement mechanism for BiOCl/OVs-BiPO_(4)heterojunctions was proposed to elucidate the boosted photocatalytic performance.This work offers a facile and reliable reference to design high performance BiPO_(4)-based photocatalysts for environment purification.
基金by the National Natural Science Foundation of China(No.81700453).
文摘Current treatments for advanced hepatocellular carcinoma(HCC)have limited success in improving patients’quality of life and prolonging life expectancy.The clinical need for more efficient and safe therapies has contributed to the exploration of emerging strategies.Recently,there has been increased interest in oncolytic viruses(OVs)as a therapeutic modality for HCC.OVs undergo selective replication in cancerous tissues and kill tumor cells.Strikingly,pexastimogene devacirepvec(Pexa-Vec)was granted an orphan drug status in HCC by the U.S.Food and Drug Administration(FDA)in 2013.Meanwhile,dozens of OVs are being tested in HCC-directed clinical and preclinical trials.In this review,the pathogenesis and current therapies of HCC are outlined.Next,we summarize multiple OVs as single therapeutic agents for the treatment of HCC,which have demonstrated certain efficacy and lowtoxicity.Emerging carrier cell-,bioengineered cell mimetic-or nonbiological vehicle-mediated OV intravenous delivery systems in HCC therapy are described.In addition,we highlight the combination treatments between oncolytic virotherapy and other modalities.Finally,the clinical challenges and prospects of OV-based biotherapy are discussed,with the aim of continuing to develop a fascinating approach in HCC patients.
文摘针对软件定义网络中控制器单点(Software Defined Network,SDN)运行隐患的问题,本文设计一种基于Ryu控制器的一主多备集群式控制器(Cluster Ryu Controller,CRC),实现自定义OVS交换机(OpenVSwitch)连接、事件上报、状态查看、流表下发等功能。通过Ryu+mininet工具进行仿真实验,结果表明,当CRC中某一控制器出现故障时,不会影响到CRC与整个网络的稳定运行,有效提升SDN网络的健壮性与可靠性。
